Lv35
350 积分 2021-05-08 加入
Accelerating and optimising CAR T-cell manufacture to deliver better patient products
4天前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
13天前
已完结
In Vivo Generation of Functional CD19 CAR-T Cells Using a Serum-Stable CD3-Targeted Lentiviral Vector
15天前
已完结
In Vivo Generation of Functional CD19 CAR-T Cells Using a Serum-Stable CD3-Targeted Lentiviral Vector
15天前
已关闭
Design of customized coronavirus receptors
16天前
已完结
Ovarian cancer-derived IL-4 promotes immunotherapy resistance
20天前
已完结
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancer
29天前
已完结
Human OX40L–CAR-T regs target activated antigen-presenting cells and control T cell alloreactivity
29天前
已完结
In vivo human T cell engineering with enveloped delivery vehicles
30天前
已完结
From suppressor to enhancer: IL-10’s alternative role in CAR-T cell therapies against solid tumors
30天前
已完结
皖公网安备34019202002308
